Dermaliq Therapeutics
Phase 3The skin is unique in many ways, but no other organ is so visible and demands so much attention and care in both diseased and healthy states.
Founded
2015
Focus
Drug Delivery
About
The skin is unique in many ways, but no other organ is so visible and demands so much attention and care in both diseased and healthy states.
Funding History
1Total raised: $5M
Seed$5MHigh-Tech GründerfondsMar 15, 2022
Company Info
TypePrivate
Founded2015
LocationBerlin, Germany
StagePhase 3
Contact
Sectors
SIMILAR COMPANIES
300Microns
Pre-clinical · Munich
BetaSense
Pre-clinical · Berlin
AB Diagnostic Systems
Pre-clinical · Jena
bbi-biotech
Pre-clinical · Berlin
Mireca Medicines
Pre-clinical · Munich
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile